Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 1:265:112494.
doi: 10.1016/j.drugalcdep.2024.112494. Epub 2024 Nov 5.

Selective dopamine D3 receptor partial agonist (±)VK4-40 reduces the reinforcing strength of d-amphetamine but not cocaine in rhesus monkeys responding under a progressive-ratio schedule of reinforcement

Affiliations

Selective dopamine D3 receptor partial agonist (±)VK4-40 reduces the reinforcing strength of d-amphetamine but not cocaine in rhesus monkeys responding under a progressive-ratio schedule of reinforcement

Mia I Allen et al. Drug Alcohol Depend. .

Abstract

Background: Although countless studies have aimed to identify and test novel therapeutics for stimulant misuse, there are still no FDA-approved pharmacotherapies for stimulant use disorders. One potential treatment target is the dopamine D3 receptor (D3R) and studies in rodents have suggested that the novel D3R partial agonist (±)VK4-40 may be effective at decreasing cocaine self-administration. However, no previous studies have examined the efficacy of (±)VK4-40 in reducing cocaine self-administration in nonhuman primates nor the generality of effects by examining self-administration of other stimulants using a within-subjects design.

Methods: Experiment 1 examined how acute treatment with (±)VK4-40 (1.7-3.0mg/kg, i.v.) influenced cocaine and d-amphetamine self-administration in three rhesus monkeys responding under a progressive-ratio (PR) schedule of reinforcement. In Experiment 2, the reinforcing effects of (±)VK4-40 were evaluated under a PR schedule and compared to cocaine and d-amphetamine.

Results: When given as a pretreatment, (±)VK4-40 significantly reduced the reinforcing strength of d-amphetamine but not cocaine. In general, the effects of (±)VK4-40 on d-amphetamine responding were parallel downward shifts in the self-administration dose-response curve. When (±)VK4-40 was substituted for cocaine, it functioned as a reinforcer in 2 of 3 monkeys. However, the reinforcing strength of (±)VK4-40 was significantly lower than cocaine and d-amphetamine, suggesting lower potential for misuse.

Conclusions: Overall, these findings support further exploration of D3R partial agonists, including (±)VK4-40, for treatment of d-amphetamine misuse or potentially in combination with d-amphetamine for treatment of cocaine use disorder.

Keywords: Cocaine; Monkey; Pharmacotherapies; Self-administration; d-amphetamine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

References

    1. Mattiuzzi C and Lippi G, Worldwide epidemiology of alcohol and drugs abuse. European journal of internal medicine, 2019. 70: p. e27–e28. - PubMed
    1. Martins SS, et al., Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. American journal of public health, 2015. 105(11): p. e29–e49. - PMC - PubMed
    1. Knopf A, 2022 NSDUH finds most people with SUD don’t seek treatment. Alcoholism & Drug Abuse Weekly, 2023. 35(45): p. 3–5.
    1. Manthey J, et al., Estimating the economic consequences of substance use and substance use disorders. Expert Review of Pharmacoeconomics & Outcomes Research, 2021. 21(5): p. 869–876. - PubMed
    1. Hedegaard H, et al., Drug overdose deaths in the United States, 1999–2020. 2021. - PubMed

MeSH terms

LinkOut - more resources